0 Replies
Copenhagen, February 11th, 2008 Santaris Pharma, the Danish biopharmaceutical company, developing LNA based RNA medicines, announced today that Keith McCullagh, President and Chief Executive Officer, will be presenting an overview of the company and its goals for 2008 at the BioIndustry Organisation’s 10th Annual CEO & Investor Conference in New York,... Contine Reading & Discuss→
0 Replies
København, d. 11. Februar, 2008 Biotekvirksomheden Santaris Pharma, som udvikler LNA-baserede RNA lægemidler, meddeler, at CEO Keith McCullagh, præsenterer virksomhedens og dens mål for 2008 på BioIndustry Organisations 10. årlige CEO & Investor Konference i New York, i dag, mandag d. 11. februar kl. 18.30 dansk tid. Konferencen finder sted på... Contine Reading & Discuss→
